Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

Low levels of ferritin and vitamin B12 are common in women with telogen effluvium, but the link between nutrient deficiencies and the condition is not clear.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

PCOS symptoms vary by age, affecting diagnosis and treatment.

Preparing and learning about menopause can improve women's quality of life as they approach this phase.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Frontal Fibrosing Alopecia may be a complex condition linked to hormonal changes in women, not just a form of Lichen Planopilaris.

Chemotherapy caused a woman's permanent hair loss and early menopause.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

A woman developed male characteristics after using unregulated hormone therapy.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

GLP-1RA therapy may increase the risk of hair loss.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The document suggests simplifying alopecia diagnosis and improving techniques for better accuracy.